Author

Cameron Bell

Cancer Research Horizons

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A.P. TurnbulliD· 1 shared Adán Pinto-FernándeziD· 1 shared Akane KawamuraiD· 1 shared Anthony C. VarcaiD· 1 shared Benedikt Mathias KessleriD· 1 shared Christopher J. DinsmoreiD· 1 shared Claire HerideiD· 1 shared Daniel V. EbneriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A.P. TurnbullORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Refined USP25/28 inhibitors with enhanced selectivity towards c-Myc driven squamous lung cancer cells

Adán Pinto-Fernández, Claire Heride, A.P. Turnbull, Dora C. S. Pedroso, Victoria Smith, Lisa Mullee, Wojciech W. Krajewski, Cameron Bell, Anthony C. Varca, Thomas M. Charlton, Dylan T. Jones, Tom E. McAllister, Roman Fischer, Elena Navarro‐Guerrero, Daniel V. Ebner, , Benedikt Mathias Kessler

This study develops refined USP25/28 inhibitors that selectively target c-MYC driven squamous lung cancer cells with reduced off-target effects and toxicity.

bioRxiv · Jun 18, 2026 · PreprintCancer Biology